Welcome!

News Feed Item

Acute Heart Failure Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Acute Heart Failure Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

Acute Heart Failure Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Acute Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Acute Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Heart Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Heart Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 6
Acute Heart Failure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Acute Heart Failure 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29

Prominent Sponsors 30
Top Companies Participating in Acute Heart Failure Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Acute Heart Failure 33
Jul 28, 2014: Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Nile Therapeutics, Inc. 35
Clinical Trial Overview of Nile Therapeutics, Inc. 35
Cardiorentis AG 36
Clinical Trial Overview of Cardiorentis AG 36
Amgen Inc. 37
Clinical Trial Overview of Amgen Inc. 37
Abbott Laboratories 38
Clinical Trial Overview of Abbott Laboratories 38
Cytokinetics, Inc. 39
Clinical Trial Overview of Cytokinetics, Inc. 39
Biogen Idec Inc. 40
Clinical Trial Overview of Biogen Idec Inc. 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Alere Inc. 42
Clinical Trial Overview of Alere Inc. 42

Actelion Ltd 43
Clinical Trial Overview of Actelion Ltd 43
Clinical Trial Overview of Top Institutes / Government 44
Duke University 44
Clinical Trial Overview of Duke University 44
National Cerebral and Cardiovascular Center 45
Clinical Trial Overview of National Cerebral and Cardiovascular Center 45
University Hospital Basel 46
Clinical Trial Overview of University Hospital Basel 46
Assistance Publique - Hopitaux de Paris 47
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 47
French Cardiology Society 48
Clinical Trial Overview of French Cardiology Society 48
Northwestern University 49
Clinical Trial Overview of Northwestern University 49
University Hospital of Larissa 50
Clinical Trial Overview of University Hospital of Larissa 50
The Cleveland Clinic 51
Clinical Trial Overview of The Cleveland Clinic 51
Hebei Medical University 52
Clinical Trial Overview of Hebei Medical University 52
YAMAGUCHI UNIVERSITY 53
Clinical Trial Overview of YAMAGUCHI UNIVERSITY 53
Five Key Clinical Profiles 54
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83

List of Tables

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region, 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Acute Heart Failure Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 34
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Nile Therapeutics, Inc., 2014* 35
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiorentis AG, 2014* 36

Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 37
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 38
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokinetics, Inc., 2014* 39
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 40
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 41
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Alere Inc., 2014* 42
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 43
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 44
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cerebral and Cardiovascular Center, 2014* 45
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 46
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 47
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by French Cardiology Society, 2014* 48
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 49
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Larissa, 2014* 50
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014* 51
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hebei Medical University, 2014* 52
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by YAMAGUCHI UNIVERSITY, 2014* 53

List of Figures

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 82

To order this report: Acute Heart Failure Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Sheng Liang to Keynote at SYS-CON's 19th Cloud Expo, which will take place on November 1-3, 2016 at the Santa Clara Convention Center in Santa Clara, California.
Ask someone to architect an Internet of Things (IoT) solution and you are guaranteed to see a reference to the cloud. This would lead you to believe that IoT requires the cloud to exist. However, there are many IoT use cases where the cloud is not feasible or desirable. In his session at @ThingsExpo, Dave McCarthy, Director of Products at Bsquare Corporation, will discuss the strategies that exist to extend intelligence directly to IoT devices and sensors, freeing them from the constraints of ...
Technology vendors and analysts are eager to paint a rosy picture of how wonderful IoT is and why your deployment will be great with the use of their products and services. While it is easy to showcase successful IoT solutions, identifying IoT systems that missed the mark or failed can often provide more in the way of key lessons learned. In his session at @ThingsExpo, Peter Vanderminden, Principal Industry Analyst for IoT & Digital Supply Chain to Flatiron Strategies, will focus on how IoT de...
Complete Internet of Things (IoT) embedded device security is not just about the device but involves the entire product’s identity, data and control integrity, and services traversing the cloud. A device can no longer be looked at as an island; it is a part of a system. In fact, given the cross-domain interactions enabled by IoT it could be a part of many systems. Also, depending on where the device is deployed, for example, in the office building versus a factory floor or oil field, security ha...
24Notion is full-service global creative digital marketing, technology and lifestyle agency that combines strategic ideas with customized tactical execution. With a broad understand of the art of traditional marketing, new media, communications and social influence, 24Notion uniquely understands how to connect your brand strategy with the right consumer. 24Notion ranked #12 on Corporate Social Responsibility - Book of List.
Businesses are struggling to manage the information flow and interactions between all of these new devices and things jumping on their network, and the apps and IT systems they control. The data businesses gather is only helpful if they can do something with it. In his session at @ThingsExpo, Chris Witeck, Principal Technology Strategist at Citrix, will discuss how different the impact of IoT will be for large businesses, expanding how IoT will allow large organizations to make their legacy ap...
Fact is, enterprises have significant legacy voice infrastructure that’s costly to replace with pure IP solutions. How can we bring this analog infrastructure into our shiny new cloud applications? There are proven methods to bind both legacy voice applications and traditional PSTN audio into cloud-based applications and services at a carrier scale. Some of the most successful implementations leverage WebRTC, WebSockets, SIP and other open source technologies. In his session at @ThingsExpo, Da...
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
What happens when the different parts of a vehicle become smarter than the vehicle itself? As we move toward the era of smart everything, hundreds of entities in a vehicle that communicate with each other, the vehicle and external systems create a need for identity orchestration so that all entities work as a conglomerate. Much like an orchestra without a conductor, without the ability to secure, control, and connect the link between a vehicle’s head unit, devices, and systems and to manage the ...
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
What does it look like when you have access to cloud infrastructure and platform under the same roof? Let’s talk about the different layers of Technology as a Service: who cares, what runs where, and how does it all fit together. In his session at 18th Cloud Expo, Phil Jackson, Lead Technology Evangelist at SoftLayer, an IBM company, spoke about the picture being painted by IBM Cloud and how the tools being crafted can help fill the gaps in your IT infrastructure.
SYS-CON Events announced today that Niagara Networks will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
In this strange new world where more and more power is drawn from business technology, companies are effectively straddling two paths on the road to innovation and transformation into digital enterprises. The first path is the heritage trail – with “legacy” technology forming the background. Here, extant technologies are transformed by core IT teams to provide more API-driven approaches. Legacy systems can restrict companies that are transitioning into digital enterprises. To truly become a lea...
SYS-CON Events announced today that Interface Masters Technologies, a leader in Network Visibility and Uptime Solutions, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Interface Masters Technologies is a leading vendor in the network monitoring and high speed networking markets. Based in the heart of Silicon Valley, Interface Masters' expertise lies in Gigabit, 10 Gigabit and 40 Gigabit Eth...
In his session at @ThingsExpo, Kausik Sridharabalan, founder and CTO of Pulzze Systems, Inc., will focus on key challenges in building an Internet of Things solution infrastructure. He will shed light on efficient ways of defining interactions within IoT solutions, leading to cost and time reduction. He will also introduce ways to handle data and how one can develop IoT solutions that are lean, flexible and configurable, thus making IoT infrastructure agile and scalable.